Citation Information :
Yadav D. Efficacy and Safety of Mifepristone Followed by Vaginal PGE1 vs PGE2 Gel Alone for Induction of Labor in Late Intrauterine Fetal Demise. J South Asian Feder Obs Gynae 2023; 15 (4):409-411.
Objective: To compare the efficacy and safety of mifepristone followed by vaginal misoprostol vs dinoprostone gel alone in induction of labor in late intrauterine fetal demise.
Methods: We conducted a randomized controlled study in 70 patients in tertiary care center from October 2020 to March 2022. In group I, 35 women were induced by using mifepristone (200 mg) orally followed by misoprostol. The dose was 100 µg per vaginal in patients with less than 37 weeks of gestation every 4 hourly and 50 µg in patients with more than 37 weeks of gestational age. In women with previous lower segment cesarean section, one dose was of 50 µg of misoprostol. In group II, 35 women were induced by intravaginal PGE2 (dinoprostone) gel 0.5 mg intravaginally (maximum two doses in 24 hours). Oxytocin was given in both groups for augmentation when needed.
Results: The mean induction delivery interval in group I was 10.67 ± 6.751 hours and in group II was 14.51 ± 5.338 hours. Mean induction delivery interval was significantly shorter in the combined regimen than dinoprostone gel-alone group (p-value=0.0103).
Conclusion: To conclude our regimen using mifepristone and misoprostol for induction of labor is an effective, less invasive, and safe combination. It results in shorter induction-to-delivery interval than dinoprostone gel.
Gray F, Keneth J, Steven L, et al. Williams Obstetrics Book, Edition 24. Chapter 35: Stillbirth 2014; vol. 24. pp. 661–666.
Biswas T. Misoprostol (PGE1) versus dinoprostone gel (PGE2) in induction of labour in late intra uterine fetal death with unfavourable cervix: A prospective comparative study. Int J Reprod, Contracept, Obstet Gynecol 2015;4(1):35–38. DOI: 10.5455/2320-1770.ijrcog20150206.
Siassakos D, Fox R, Draycott T, et al. Late intrauterine fetal death and still birth. Green Top Guideline no. 55; October 2010.
Trivedi K, Swati A, Shrivastava P, et al. Mifepristone followed by prostaglandin vs. prostaglandin alone for induction of labour in intrauterine foetal death at or more than 2 weeks of pregnancy. Int J Contemp Med Res 2019;6(10):J5–J9. DOI: 10.21276/ijcmr.2019.6.10.24.
Wagaarachchi PT, Ashok PW, Smith NC, et al. Medical management of early fetal demise using sublingual misoprostol. BJOG 2002;109(4):462–465. DOI: 10.1111/j.1471-0528.2002.01075.x.
Maheshwari S, Borgohain D. Method of induction of labor in intrauterine fetal demise: A comparative study. Int J Reprod Contracept Obstet Gynecol 2017;6(9):3911–3914. DOI: 10.18203/2320-1770.ijrcog20174033.
Raghavan JV, Pillai SK, Meera D. Intracervical dinoprostone versus sublingual misoprostol for preinduction ripening of cervix. Indian J Obstet Gynecol Res 2017;4(1):71–76.
Qazi Q, Fatima SS, Wahab S, et al. Efficacy of misoprostol and prostaglandin E2 gel for induction of labor in term pregnancy. J Postgraduate Med Institute 2019;33(4):331–336.
Gupta S, Kagathra B, Desai A. Mifepristone and misoprostol versus misoprostol alone in management of late intrauterine fetal death. Int J Reprod, Contracept, Obstet Gynecol 2016;5(9):2935–2939. DOI: 10.18203/2320-1770.ijrcog20162882.
Amin KV, Chauhan AR, Goel A. Current practices of cervical ripening and induction of labour in intrauterine foetal demise: An observational study. J Obstet Gynaecol India 2019;69(1):37–42. DOI: 10.1007/s13224-017-1085-1.
Agrawal A, Basnet P, Thakur A, et al. Induction of labor using misoprostol with or without mifepristone in intrauterine death. JNMA J Nepal Med Assoc 2014;52(194):785–790. PMID: 26905705.
